We deliver process-embedded, GMP-compliant full-set engineering services tailored for fusion protein manufacturing, covering clinical pilot-scale workshops and commercial-grade production facilities. Our integrated engineering scope covers master facility zoning, upstream cell culture and fermentation layout, downstream multi-stage purification configuration, sterile formulation process design and supporting utility system integration. Targeting the unique characteristics of fusion proteins—including complex structural attributes, high impurity sensitivity and strict consistency requirements—our process-driven design eliminates layout defects and operational deviations, building audit-ready manufacturing infrastructure for stable batch quality control and global regulatory submission.
Our fusion protein manufacturing engineering adheres to core philosophies of process reproducibility optimization, hierarchical contamination control, low-deviation scale-up logic and multi-product flexible compatibility. We adopt scientifically graded cleanroom zoning and directional pressure cascade systems to isolate seed cultivation, protein expression, purification and sterile finishing workflows, effectively preventing cross-contamination and bioburden fluctuation. Optimized sanitary piping, zero-dead-volume fluid paths and standardized CIP/SIP frameworks ensure stable removal of host cell proteins, residual DNA and endotoxin impurities. Modular skid-based layout reserves scalable interfaces to support process optimization, titer upgrading and phased capacity expansion.
All engineering design standards, construction specifications and process configuration logic fully comply with FDA, EMA Annex 1, ICH Q8/Q9/Q10 and ISPE biomanufacturing guidelines for complex protein therapeutics. We deploy 21 CFR Part 11 compliant data integrity and environmental monitoring systems to achieve full traceability of process parameters, equipment operation status and batch production records. Every engineering detail is optimized for fusion protein quality consistency and comparability, sustaining long-term audit readiness for international GMP inspections, clinical trial validation and cross-border product market authorization.
We provide end-to-end lifecycle engineering support including project feasibility assessment, conceptual and detailed facility design, process scale-up verification, on-site construction supervision, system commissioning and complete IQ/OQ/PQ qualification delivery. Our fusion protein-centric engineering solution bridges facility construction and process operation, minimizes batch variation and production loss, and reduces long-term operational compliance risks. Clients obtain highly stable, scalable and regulation-compliant manufacturing systems to accelerate product industrialization, lower overall production costs and enhance core competitiveness in the global biotherapeutic market.
